Thomaspartners’s Pfizer PFE Stock Holding History

Thomaspartners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$276M	Buy	8,196,496 +240,149	+3%	+$8.26M	2.02%	20
2017 Q4	$273M	Buy	7,956,347 +223,817	+3%	+$7.63M	2%	18
2017 Q3	$262M	Buy	7,732,530 +241,556	+3%	+$7.76M	2.1%	18
2017 Q2	$239M	Buy	7,490,974 +494,547	+7%	+$15.6M	2.05%	21
2017 Q1	$227M	Buy	6,996,427 +701,293	+11%	+$22.1M	2.09%	19
2016 Q4	$194M	Buy	6,295,134 +560,038	+10%	+$17.1M	2.1%	20
2016 Q3	$184M	Buy	5,735,096 +361,042	+7%	+$12.1M	2.25%	15
2016 Q2	$180M	Buy	5,374,054 +299,489	+6%	+$9.56M	2.35%	15
2016 Q1	$143M	Buy	5,074,565 +213,454	+4%	+$6.1M	2.05%	19
2015 Q4	$149M	Buy	4,861,111 +144,205	+3%	+$4.54M	2.29%	7
2015 Q3	$141M	Buy	4,716,906 +45,082	+1%	+$1.45M	2.37%	6
2015 Q2	$149M	Buy	4,671,824 +66,558	+1%	+$2.17M	2.4%	2
2015 Q1	$152M	Buy	4,605,266 +298,143	+7%	+$9.48M	2.47%	1
2014 Q4	$127M	Buy	4,307,123 +361,844	+9%	+$10.4M	2.19%	8
2014 Q3	$111M	Buy	3,945,279 +315,487	+9%	+$8.85M	2.16%	11
2014 Q2	$102M	Buy	3,629,792 +634,775	+21%	+$18.1M	2.13%	10
2014 Q1	$91.3M	Buy	2,995,017 +855,317	+40%	+$25.5M	2.19%	3
2013 Q4	$62.2M	Buy	2,139,700 +424,697	+25%	+$12.4M	1.71%	32
2013 Q3	$46.7M	Buy	1,715,003 +359,004	+26%	+$9.77M	1.68%	26
2013 Q2	$40.1M	Buy	+1,355,999	New	+$37.5M	1.57%	29

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thomaspartners's PFE Position: Q1 2018 in Review

Thomaspartners increased its Pfizer (PFE) stake by 3% in Q1 2018, buying an estimated $8.26M and bringing the position to 8,196,496 shares worth $276M. The position accounts for 2.02% of the portfolio, ranked #20.

Thomaspartners first reported a position in PFE in Q2 2013 and has held it in 20 quarters since. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

Thomaspartners held 8,196,496 shares of Pfizer worth $276M as of Q1 2018.
Thomaspartners bought 240,149 Pfizer shares in Q1 2018, an estimated $8.26M.
Pfizer made up 2.02% of Thomaspartners's portfolio in Q1 2018, its #20 holding.
Thomaspartners first reported a position in Pfizer in Q2 2013 and has held it in 20 quarters since.
2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Thomaspartners's 13F filing for Q1 2018, filed 2 May 2018.